![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Dishman Pharmaceuticals Board Recommends 25 Percent Dividend
Dishman Pharmaceuticals Board Recommends 25 Percent Dividend
Dishman Pharmaceuticals & Chemicals board has recommended the final dividend at 25 percent on the paid-up equity share capital of the company, for the financial year 2004-2005. The board has also re-appointed Rajnikant T Vyas as the chairman and managing director of the company, for a further period of 5 years, with effect from July 1, 2005, subject to approval of the members in general meeting. The present term of Rajnikant T Vyas expires on June 30, 2005.
()a href="http://feeds.bignewsnetwork.com/redir.php?jid=3304857c3904d78d&cat=6dcd932030878143" target="_blank">Big News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct